Article
Molecular oncology of lung cancer.
General thoracic and cardiovascular surgery - 1 Aug 2011
Toyooka Shinichi, Mitsudomi Tetsuya, Soh Junichi, Aokage Keiju, Yamane Masaomi, Oto Takahiro, Kiura Katsuyuki, Miyoshi Shinichiro
Abstract excerpt
Progress in genetic engineering has made it possible to elucidate the molecular biological abnormalities in lung cancer. Mutations in KRAS and P53 genes, loss of specific alleles, and DNA methylation of the tumor suppressor genes were the major abnormalities investigated between 1980 and the 2000s. In 2004, mutations in the epidermal growth factor receptor (EGFR) gene that cause oncogene addiction were discovered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
